Matching slides 3,748
Current window 2,791-2,820
Pages 125
Rows per page 30
Beat: Problem Agitate Solution Problem Identify Painclear collectionreset all

Beat

2,791-2,820 of 3,748

filter-aware
01
Slide 1
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
02
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
03
Uses external analyst quotes to validate the activist's position on valuation.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
04
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
05
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
06
The slide uses a three-column structure to present the activist's thesis.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
07
Includes a line chart comparing Avalara's 3-year TSR against comparable public companies and the S&P Software Index.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
08
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
09
The slide highlights a flawed sale process and negative shareholder/analyst sentiment.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
09
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
10
The chart uses a stacked bar approach to show captured vs. estimated visits, with trend lines indicating growth rates.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
11
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
12
The slide uses a circular infographic layout to connect a visual of cannabis products to three distinct risk categories.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
The chart uses a dual-line comparison to show the divergence in risk outcomes based on treatment timing.Aquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
04
The slide uses academic citations to establish the clinical relevance of the target protein.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
Includes a scientific diagram of the signaling pathway and references to academic literature.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
06
Includes a bifurcation diagram illustrating the relationship between SNAIL and ZEB mRNA levels in different cell phenotypes.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
06
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
04
The slide uses a timeline-style visualization for clinical trial phases.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
05
Context Therapeutics | Investor Presentation Deck | 25 slidesContext Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
09
The slide uses stacked bar charts to compare response rates (Complete, Partial, No Response) at different time intervals for two drugs.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a numbered list format to categorize six distinct macro issues, each paired with a supporting news clipping.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
Uses a process flow diagram to contrast current state (central lab) vs future state (POC).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
09
The slide uses a list of pain points on the left and illustrative examples of existing POC devices on the right.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
10
Uses a photo of a lab bench to illustrate the 'proliferation of instruments' pain point.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
03
SkyHarbour | Investor Presentation Deck | 8 slidesSkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations Beat · Problem1 hit
04
The slide outlines a financial challenge (funding gap) and specific operational strategies to address it.SkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
01
Slide 1
Exhibit 99.2 identifier present.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem1 hit
02
TCR2 Therapeutics | Results Presentation Deck | 34 slidesTCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem1 hit
03
TCR2 Therapeutics | Results Presentation Deck | 34 slidesTCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · Problem1 hit